Von Hippel-Lindau disease

Active Research Protocols

  1. 00-CH-0093 – Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma
  2. 00-N-0140 – A Prospective Natural History Study of VHL Patients with CNS Hemangioblastomas
  3. 03-C-0145 – Evaluation of the Natural History and Management of Pancreatic Lesions Associated with Von Hippel-Lindau
  4. 04-C-0238 – A Phase II Study of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Von Hippel Lindau Disease and Renal Tumors
  5. 08-C-0020 – A Phase 2 Study of ZD6474 (Vandetanib) in Patients with Von Hippel Lindau Disease and Renal Tumors
  6. 10-C-0114 – A Phase II Study of Bevacizumab and Erlotinib in Subjects with Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
  7. 12-EI-0042 – NEI Intramural Biorepository for Retinal Diseases
  8. 89-C-0086 – Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
  9. 99-C-0053 – Von Hippel-Lindau (VHL) Disease Genetic Epidemiology Study
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014